124 related articles for article (PubMed ID: 24044568)
1. Defining the seriousness of proliferative vitreoretinopathy by aspiration of cytokines from the anterior chamber.
Rusnak S; Vrzalova J; Hecová L; Kozova M; Topolcan O; Ricarova R
Biomark Med; 2013 Oct; 7(5):759-67. PubMed ID: 24044568
[TBL] [Abstract][Full Text] [Related]
2. Anterior chamber aqueous flare is a strong predictor for proliferative vitreoretinopathy in patients with rhegmatogenous retinal detachment.
Schröder S; Muether PS; Caramoy A; Hahn M; Abdel-Salam M; Diestelhorst M; Kirchhof B; Fauser S
Retina; 2012 Jan; 32(1):38-42. PubMed ID: 21765375
[TBL] [Abstract][Full Text] [Related]
3. CONCENTRATIONS OF VITREAL CYTOKINES IN RHEGMATOGENOUS RETINAL DETACHMENT.
Danielescu C; Zugun-Eloae F; Zlei M
Rev Med Chir Soc Med Nat Iasi; 2016; 120(1):124-9. PubMed ID: 27125084
[TBL] [Abstract][Full Text] [Related]
4. Profibrotic cytokines in aqueous humour correlate with aqueous flare in patients with rhegmatogenous retinal detachment.
Hoerster R; Hermann MM; Rosentreter A; Muether PS; Kirchhof B; Fauser S
Br J Ophthalmol; 2013 Apr; 97(4):450-3. PubMed ID: 23355528
[TBL] [Abstract][Full Text] [Related]
5. Antiangiogenic isoforms of vascular endothelial growth factor predominate in subretinal fluid of patients with rhegmatogenous retinal detachment and proliferative vitreoretinopathy.
Ricker LJ; Dieudonné SC; Kessels AG; Rennel ES; Berendschot TT; Hendrikse F; Kijlstra A; La Heij EC
Retina; 2012 Jan; 32(1):54-9. PubMed ID: 21836532
[TBL] [Abstract][Full Text] [Related]
6. Retinal detachment and proliferative vitreoretinopathy: central retinal artery blood velocities, intraocular pressure, and endothelin 1.
Roldán-Pallarés M; Musa AS; Hernández-Montero J; Bravo-Llatas Sc C; Fernández-Durango R
Retina; 2013 Sep; 33(8):1528-39. PubMed ID: 23974951
[TBL] [Abstract][Full Text] [Related]
7. Vitreous vascular endothelial growth factor concentrations in proliferative diabetic retinopathy versus proliferative vitreoretinopathy.
Citirik M; Kabatas EU; Batman C; Akin KO; Kabatas N
Ophthalmic Res; 2012; 47(1):7-12. PubMed ID: 21691136
[TBL] [Abstract][Full Text] [Related]
8. Analysis of the molecular biologic milieu of the vitreous in proliferative vitreoretinopathy.
Wladis EJ; Falk NS; Iglesias BV; Beer PM; Gosselin EJ
Retina; 2013 Apr; 33(4):807-11. PubMed ID: 23222459
[TBL] [Abstract][Full Text] [Related]
9. Levels of some cytokines in subretinal fluid in proliferative vitreoretinopathy and rhegmatogenous retinal detachment.
Kenarova B; Voinov L; Apostolov C; Vladimirova R; Misheva A
Eur J Ophthalmol; 1997; 7(1):64-7. PubMed ID: 9101198
[TBL] [Abstract][Full Text] [Related]
10. [Relaxing peripheral retinotomy with endolaser in treatment of retinal detachment with severe anterior proliferative vitreoretinopathy].
Li X; Jiang Y
Zhonghua Yan Ke Za Zhi; 1998 Nov; 34(6):411-4. PubMed ID: 11877240
[TBL] [Abstract][Full Text] [Related]
11. Balance of vascular endothelial growth factor and pigment epithelial growth factor prior to development of proliferative vitreoretinopathy.
Dieudonné SC; La Heij EC; Diederen RM; Kessels AG; Liem AT; Kijlstra A; Hendrikse F
Ophthalmic Res; 2007; 39(3):148-54. PubMed ID: 17534114
[TBL] [Abstract][Full Text] [Related]
12. [Lenticular-vitreoretinal surgery for complicated retinal detachment].
Liu W; Wang J; Chen S
Zhonghua Yan Ke Za Zhi; 1997 May; 33(3):207-9. PubMed ID: 10437038
[TBL] [Abstract][Full Text] [Related]
13. Conventional retinal surgery for rhegmatogenous retinal detachment with proliferative vitreoretinopathy.
Ivanisević M
Acta Med Croatica; 1995; 49(4-5):207-9. PubMed ID: 8630455
[TBL] [Abstract][Full Text] [Related]
14. [Retinal detachment with anterior proliferative vitreoretinopathy and its surgical treatment].
Liu W; Wang J; Chen H
Zhonghua Yan Ke Za Zhi; 2000 Sep; 36(5):351-4. PubMed ID: 11853627
[TBL] [Abstract][Full Text] [Related]
15. Substance P in proliferative vitreoretinopathy: the significance of aqueous humor levels for evolution of the disease.
Troger J; Kremser B; Irschick E; Göttinger W; Kieselbach G
Graefes Arch Clin Exp Ophthalmol; 1998 Dec; 236(12):900-3. PubMed ID: 9865620
[TBL] [Abstract][Full Text] [Related]
16. Intercellular adhesion molecule-1 in proliferative vitreoretinopathy.
Limb GA; Chignell AH; Cole CJ; Green WT; Webster L; Hollifield RD; Dumonde DC
Invest Ophthalmol Vis Sci; 1997 Apr; 38(5):1043-8. PubMed ID: 9113001
[TBL] [Abstract][Full Text] [Related]
17. Clinical results of Densiron 68 intraocular tamponade for complicated retinal detachment.
Li W; Zheng Q; Wang X; Xu M; Wu R
Ophthalmologica; 2010; 224(6):354-60. PubMed ID: 20453542
[TBL] [Abstract][Full Text] [Related]
18. Glial remodeling and neural plasticity in human retinal detachment with proliferative vitreoretinopathy.
Sethi CS; Lewis GP; Fisher SK; Leitner WP; Mann DL; Luthert PJ; Charteris DG
Invest Ophthalmol Vis Sci; 2005 Jan; 46(1):329-42. PubMed ID: 15623793
[TBL] [Abstract][Full Text] [Related]
19. [Scleral compression in assessment of the stage of proliferative vitreoretinopathy and type of subretinal contents in retinal detachment].
Il'nitskiĭ VV; Saksonova EO; Movshovich AI
Vestn Oftalmol; 1994; 110(3):12-4. PubMed ID: 7810033
[TBL] [Abstract][Full Text] [Related]
20. C-C chemokines in the vitreous of patients with proliferative vitreoretinopathy and proliferative diabetic retinopathy.
Capeans C; De Rojas MV; Lojo S; Salorio MS
Retina; 1998; 18(6):546-50. PubMed ID: 9869464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
